Are monoclonal antibodies a safe treatment for cancer during pregnancy? - Wikidata - awgldk - TriplyDB

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

http://www.wikidata.org/entity/Q38119550

about

Review on renal cell carcinoma and pregnancy: A challenging situation Preeclampsia: long-term consequences for vascular health Treatment of gynecological cancers diagnosed during pregnancy.Ovarian function following targeted anti-angiogenic therapy with bevacizumab The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model.Management of Hematologic Malignancies: Special Considerations in Pregnant Women.Anticancer drugs during pregnancy.Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy?Cancer during pregnancy.Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria

P2860

Q26740595-12C31271-D299-4A18-906B-7E969A6EB70F Q26800272-7F82D63B-D846-4EB2-B115-FD002FA44E97 Q30249061-9363ACB2-FB58-4AAB-9DE9-90BFEE56A1D0 Q33748232-9276C5CD-7BD3-4E20-BD95-EE56BCC04EE7 Q36884383-823088E1-6F3E-42F7-B459-D5AC91B1EC8A Q37117375-7557C235-E024-417F-85C5-60D46EFE0EC7 Q38594889-1E2C838F-3FC3-4F93-B8B3-B8DCB256BD3C Q38860947-B6671C00-B8FC-42A6-8D7A-1111663A7F1F Q46307098-B027F8F5-3AD4-4CEC-85B9-2C609A7FFC3B Q53093490-26C21A3B-702E-492E-8B48-EFAE25A6091B Q58566399-FB914572-1F2B-4489-8594-209AA1AC14F5

P2860

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

http://www.wikidata.org/entity/Q38119550

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

@en

type

label

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

@en

prefLabel

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

@en

P1433

Q38119550-67450B70-360E-4321-B75A-4A505E328A8F

P1476

Q38119550-69EEC1C7-DD0D-415D-9FC1-BFC67DF6A6A0

P2093

Q38119550-59A9023E-19B2-4041-90E3-7947A47FE129

Q38119550-92CF96EB-D4B8-4785-8D36-5F4009434CFA

Q38119550-ED367A34-DC57-4AD9-9F85-5F61D4808AF7

Q38119550-F06A1CB2-82C7-43EC-A0DF-8B4B7FDCEFFC

P2860

Q38119550-07D2B488-0CD4-4A2E-89F9-0DD25DD183D3

Q38119550-1B477142-D53F-4002-81F2-8EBD24524D27

Q38119550-1C9B45B4-4A82-4F5D-A3C8-A23F0943EA98

Q38119550-1EC9E8CB-6324-486A-AE0B-C70284433F6E

Q38119550-23CADC33-04A8-49D6-A163-77574A9F6FAC

Q38119550-2FDB259C-ECAA-4CCE-A8B3-C59641C422DA

Q38119550-39047ED5-9246-4CC7-9FDD-9C2B0FFCD8A1

Q38119550-4B45F11B-E506-4586-9C38-D654A21E72ED

Q38119550-4DA3B031-19AF-4F25-9018-8686EB7B74AE

Q38119550-52368958-14E9-45B0-8A64-5F52A1D84D8A

P304

Q38119550-ECA26C5A-A739-47C3-A17B-80A0396F8D50

P31

Q38119550-9AFE1D35-FFE3-4DD9-9DA4-16F293C22EAE

P356

Q38119550-CC9AE572-5057-4274-B9BB-519E7A029E81

P433

Q38119550-694B63A7-4D56-4D2C-AE3F-5EB52E44334B

P478

Q38119550-69AE13D8-46C6-44BB-8447-0E5C73B289A7

P50

Q38119550-B3FB0F8E-0508-4B87-8403-3B047495DE16

P577

Q38119550-6BBB010E-B2FC-4547-9864-7E0458157458

P5875

Q38119550-6D35BAD7-B8DE-472F-8DDF-386BB1D39837

P698

Q38119550-5EC9ADA4-05EA-46FA-8671-5DC34D5AFAF4

P356

P1433

P1476

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

@en

P2093

Hatem A Azim

http://www.w3.org/2001/XMLSchema#string

Maria Anna Sarno

http://www.w3.org/2001/XMLSchema#string

Nicoletta Colombo

http://www.w3.org/2001/XMLSchema#string

Rosanna Mancari

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamics of immunoglobulins at the feto-maternal interface

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura

Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.

Pregnancy outcomes after maternal exposure to rituximab.

Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.

Safety of trastuzumab (Herceptin) during pregnancy: two case reports.

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

Pregnancy-associated breast cancer and metastasis.

P304

733-741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.13.64

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Fedro A Peccatori

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247154739

http://www.w3.org/2001/XMLSchema#string

P698

23829624

http://www.w3.org/2001/XMLSchema#string